JEAN JACQUES BIENAIME Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEAN JACQUES BIENAIME. JEAN JACQUES BIENAIME is Director in INCYTE CORP ($INCY) and Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in VITAL THERAPIES INC ($VTL).
Latest Insider Trading Transactions of JEAN JACQUES BIENAIME
Sentiment: All, BMRN, VTL, INCY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.44 | 5,000 | 422,200 | 170,682 | 175.7 K to 170.7 K (-2.85 %) |
| Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 175,682 | 170.7 K to 175.7 K (+2.93 %) |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 93,423 | |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 97,423 | |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.84 | 4,000 | 359,360 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.31 | 4,000 | 365,240 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 101,423 | |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 105,423 | |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.79 | 4,000 | 359,160 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.19 | 4,000 | 348,760 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 109,423 | |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 113,423 | |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.35 | 4,000 | 333,400 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.84 | 4,000 | 335,360 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
| Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
| Dec 30 2016 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 100.27 | 144 | 14,439 | 1,069 | 925 to 1.1 K (+15.57 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,743 | 1,847,492 | 140,513 | |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,744 | 1,847,519 | 210,256 | |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.69 | 69,743 | 5,976,515 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,743 | 1,847,492 | 240,425 | 170.7 K to 240.4 K (+40.86 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.56 | 69,744 | 6,106,478 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,744 | 1,847,519 | 240,426 | 170.7 K to 240.4 K (+40.86 %) |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,670 | 730,892 | 0 | |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.97 | 41,670 | 3,790,795 | 323,368 | 365 K to 323.4 K (-11.42 %) |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,670 | 730,892 | 365,038 | 323.4 K to 365 K (+12.89 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 140,000 | |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 210,000 | |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.83 | 70,000 | 5,797,806 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 70,000 | 1,505,700 | 393,368 | 323.4 K to 393.4 K (+21.65 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.52 | 70,000 | 5,776,435 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 70,000 | 1,505,700 | 393,368 | 323.4 K to 393.4 K (+21.65 %) |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 60,000 | 863,400 | 117,000 | |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 60,000 | 863,400 | 177,000 | |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 81.27 | 60,000 | 4,875,990 | 323,368 | 383.4 K to 323.4 K (-15.65 %) |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 60,000 | 863,400 | 383,368 | 323.4 K to 383.4 K (+18.55 %) |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 81.34 | 60,000 | 4,880,448 | 323,368 | 383.4 K to 323.4 K (-15.65 %) |
| Oct 31 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 60,000 | 863,400 | 383,368 | 323.4 K to 383.4 K (+18.55 %) |
| Oct 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 41,670 | |
| Oct 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.39 | 41,666 | 3,516,227 | 323,368 | 365 K to 323.4 K (-11.41 %) |
| Oct 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 365,034 | 323.4 K to 365 K (+12.89 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 11,000 | 196,460 | 11,000 | |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 53,125 | 2,050,094 | 212,500 | |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.89 | 11,000 | 955,814 | 323,368 | 334.4 K to 323.4 K (-3.29 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 11,000 | 196,460 | 334,368 | 323.4 K to 334.4 K (+3.40 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 86.98 | 53,125 | 4,620,563 | 323,368 | 376.5 K to 323.4 K (-14.11 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 53,125 | 2,050,094 | 376,493 | 323.4 K to 376.5 K (+16.43 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 200 | 0 | 377,484 | 377.7 K to 377.5 K (-0.05 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 500 | 0 | 377,684 | 378.2 K to 377.7 K (-0.13 %) |
| Oct 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 400 | 0 | 378,184 | 378.6 K to 378.2 K (-0.11 %) |
| Oct 04 2016 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 94.29 | 153 | 14,426 | 925 | 772 to 925 (+19.82 %) |
| Oct 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 53,125 | 2,050,094 | 265,625 | |
| Oct 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.02 | 53,125 | 4,888,780 | 378,584 | 431.7 K to 378.6 K (-12.31 %) |
| Oct 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 53,125 | 2,050,094 | 431,709 | 378.6 K to 431.7 K (+14.03 %) |
| Oct 03 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 53,125 | 2,050,094 | 318,750 | |
| Oct 03 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.65 | 53,125 | 4,974,901 | 378,584 | 431.7 K to 378.6 K (-12.31 %) |
| Oct 03 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 53,125 | 2,050,094 | 431,709 | 378.6 K to 431.7 K (+14.03 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 83,336 | |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 53,125 | 2,050,094 | 371,875 | |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 42,577 | 737,859 | 117,423 | |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.97 | 41,666 | 3,998,561 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.25 | 53,125 | 5,060,039 | 378,584 | 431.7 K to 378.6 K (-12.31 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 53,125 | 2,050,094 | 431,709 | 378.6 K to 431.7 K (+14.03 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 94.85 | 42,577 | 4,038,360 | 378,584 | 421.2 K to 378.6 K (-10.11 %) |
| Sep 19 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 42,577 | 737,859 | 421,161 | 378.6 K to 421.2 K (+11.25 %) |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 125,002 | |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.49 | 41,666 | 3,811,868 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 125,002 | |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.49 | 41,666 | 3,811,868 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
| Aug 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
| Jul 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 166,668 | |
| Jul 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.72 | 41,666 | 3,863,272 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
| Jul 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
| Jul 05 2016 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 79.98 | 181 | 14,476 | 772 | 591 to 772 (+30.63 %) |
| Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,666 | 730,822 | 208,334 | |
| Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.55 | 41,666 | 3,356,196 | 378,584 | 420.3 K to 378.6 K (-9.91 %) |
| Jun 20 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,666 | 730,822 | 420,250 | 378.6 K to 420.3 K (+11.01 %) |
| Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 90.00 | 6,640 | 597,600 | 378,584 | 385.2 K to 378.6 K (-1.72 %) |
| May 31 2016 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 84.53 | 15,000 | 1,267,950 | 15,000 | |
| May 26 2016 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 8.17 | 21,599 | 176,464 | 21,599 | |
| May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 82.71 | 4,932 | 407,926 | 385,224 | 390.2 K to 385.2 K (-1.26 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 20,000 | 259,800 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 20,000 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 80.80 | 5,479 | 442,703 | 390,156 | 395.6 K to 390.2 K (-1.38 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 20,000 | 1,602,978 | 0 | 20 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 20,000 | 259,800 | 20,000 | 0 to 20 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | M | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
| May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 36,500 | 474,135 | 0 | |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.01 | 36,500 | 3,102,931 | 395,635 | 432.1 K to 395.6 K (-8.45 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 36,500 | 474,135 | 432,135 | 395.6 K to 432.1 K (+9.23 %) |
| May 04 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 51.26 | 414 | 21,223 | 395,635 | 395.2 K to 395.6 K (+0.10 %) |
| Apr 01 2016 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 72.47 | 200 | 14,494 | 591 | 391 to 591 (+51.15 %) |
| Apr 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,500 | 21,585 | 237,000 | |
| Apr 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,500 | 21,585 | 238,500 | |
| Apr 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,500 | 21,585 | 395,221 | 393.7 K to 395.2 K (+0.38 %) |
| Apr 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,500 | 21,585 | 393,721 | 392.2 K to 393.7 K (+0.38 %) |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 83.43 | 136,050 | 11,350,652 | 136,050 | |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 60,710 | 0 | 392,221 | 331.5 K to 392.2 K (+18.31 %) |
| Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 89.57 | 8,989 | 805,145 | 331,511 | 340.5 K to 331.5 K (-2.64 %) |
| Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.24 | 2,828 | 238,217 | 340,500 | 343.3 K to 340.5 K (-0.82 %) |
| Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.22 | 2,151 | 181,152 | 343,328 | 345.5 K to 343.3 K (-0.62 %) |
| Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.33 | 5,021 | 423,400 | 345,479 | 350.5 K to 345.5 K (-1.43 %) |
| Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 81.87 | 192,982 | 15,799,436 | 350,500 | 543.5 K to 350.5 K (-35.51 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 21,978 | 0 | 543,482 | 521.5 K to 543.5 K (+4.21 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 198,400 | 0 | 521,504 | 323.1 K to 521.5 K (+61.40 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 94,850 | 0 | 323,104 | 228.3 K to 323.1 K (+41.55 %) |
| Dec 31 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 108.45 | 133 | 14,424 | 391 | 258 to 391 (+51.55 %) |
| Dec 02 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 94.74 | 1,000 | 94,744 | 25,758 | 26.8 K to 25.8 K (-3.74 %) |
| Oct 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 108.24 | 1,000 | 108,241 | 26,758 | 27.8 K to 26.8 K (-3.60 %) |
| Oct 02 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 110.33 | 131 | 14,453 | 258 | 127 to 258 (+103.15 %) |
| Sep 16 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 131.43 | 1,000 | 131,432 | 27,758 | 28.8 K to 27.8 K (-3.48 %) |
| Sep 11 2015 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Buy | P | 3.05 | 6,000 | 18,293 | 39,119 | 33.1 K to 39.1 K (+18.12 %) |
| Sep 11 2015 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Buy | P | 3.16 | 2,000 | 6,320 | 33,119 | 31.1 K to 33.1 K (+6.43 %) |
| Sep 11 2015 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Buy | P | 3.10 | 2,000 | 6,200 | 31,119 | 29.1 K to 31.1 K (+6.87 %) |
| Sep 11 2015 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Buy | P | 3.07 | 4,000 | 12,280 | 29,119 | 25.1 K to 29.1 K (+15.92 %) |
| Aug 13 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 134.72 | 1,500 | 202,083 | 28,758 | 30.3 K to 28.8 K (-4.96 %) |
| Jul 09 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 139.07 | 1,500 | 208,600 | 30,258 | 31.8 K to 30.3 K (-4.72 %) |
| Jul 06 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 500 | 0 | 228,754 | 229.3 K to 228.8 K (-0.22 %) |
| Jul 06 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 104.21 | 127 | 13,235 | 127 | 0 to 127 |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 120.46 | 6,640 | 799,854 | 229,254 | 235.9 K to 229.3 K (-2.81 %) |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 20,000 | |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 25,000 | |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 0.00 | 5,000 | 0 | 99,067 | 94.1 K to 99.1 K (+5.32 %) |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 0.00 | 7,500 | 0 | 94,067 | 86.6 K to 94.1 K (+8.66 %) |
| May 27 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
| May 26 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | S | 126.11 | 1,500 | 189,157 | 31,758 | 30.3 K to 31.8 K (+4.96 %) |
| May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 122.78 | 4,932 | 605,551 | 235,894 | 240.8 K to 235.9 K (-2.05 %) |
| May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 121.09 | 2,349 | 284,440 | 240,826 | 243.2 K to 240.8 K (-0.97 %) |
| May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 121.66 | 5,479 | 666,575 | 243,175 | 248.7 K to 243.2 K (-2.20 %) |
| May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 23,218 | 149,988 | 0 | |
| May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.98 | 3,505 | 402,992 | 248,654 | 252.2 K to 248.7 K (-1.39 %) |
| May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 114.98 | 23,218 | 2,669,517 | 33,258 | 56.5 K to 33.3 K (-41.11 %) |
| May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 23,218 | 149,988 | 56,476 | 33.3 K to 56.5 K (+69.81 %) |
| May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 51.26 | 908 | 46,547 | 252,159 | 251.3 K to 252.2 K (+0.36 %) |